Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-066589
Filing Date
2025-07-09
Accepted
2025-07-09 07:47:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2520134d2_defa14a.htm DEFA14A 48153
2 EXHIBIT 2.1 tm2520134d2_ex2-1.htm EX-2.1 718283
3 EXHIBIT 10.1 tm2520134d2_ex10-1.htm EX-10.1 73508
4 EXHIBIT 99.1 tm2520134d2_ex99-1.htm EX-99.1 37754
5 GRAPHIC tm2520134d2_ex99-1img001.jpg GRAPHIC 9946
  Complete submission text file 0001104659-25-066589.txt   892560
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38067 | Film No.: 251112284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)